n of 1 copertina

n of 1

One Man's Harvard-Documented Remission of Incurable Cancer Using Only Natural Methods

Anteprima
Offerta a tempo limitato
3 mesi gratis di Audible Premium
Iscriviti ora
L'offerta termina il 15 luglio 2026 alle 23:59. Approfittane!
I primi 3 mesi gratis.
Ascolto illimitato della nostra selezione in continua crescita di migliaia di audiolibri, podcast e Audible Original.
Accesso a vendite e offerte esclusive.
Dopo 3 mesi, 9,99 €/mese.

n of 1

Di: Glenn Sabin, Dawn Lemanne MD MPH, Dean Ornish MD - Foreword
Letto da: Charles Constant
Iscriviti ora

3 mesi a soli 0,99 €/mese, dopodiché 9,99 €/mese. Possibilità di disdire ogni mese. Offerta valida fino al 15 luglio 2026 alle 23.59.

Acquista ora a 9,40 €

Acquista ora a 9,40 €

Twenty-five years ago, my doctors had no cure for my cancer. So I went on a quest to find my own treatment. This is my story....

In 1991, Glenn Sabin was a 28-year-old newlywed diagnosed with chronic lymphocytic leukemia (CLL) - a disease doctors called "uniformly fatal". Treatments could buy him some time and eventually ease his discomfort, but there was no conventional cure. Glenn's prognosis was clear: He was going to die.

Although Glenn and his wife, Linda, continued to consult with doctors, cancer specialists, and top oncologists, Glenn made a monumental decision: He would become his own health advocate. While he continued to "watch and wait", Glenn would figure out how to stay alive.

No one could predict when a large-scale clinical trial would discover a cure for CLL, so Glenn began his own medically monitored and carefully researched lifestyle changes. He would conduct his own single-patient clinical trial.

He would become an "n of one".

Today, Glenn is not only alive, but a 2012 biopsy at Harvard confirmed that his bone marrow contains no leukemic cells. His case is now part of the medical literature.

©2016 FON Therapeutics, Inc. (P)2020 Tantor
Disturbo fisico e malattia Medico Professionisti e accademici
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione